Chen Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chen Liu has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Lili Kang
Department of Neonatology, Children’s Hospital Affiliated to Shandong University
2 shared publications- Hao Li
School of Biological Science and Technology, University of Jinan, 336 West Road of Nan, Xinzhuang 250022, China
1 shared publication - Hongkai Liu
Univ Jinan, Coll Culture & Tourism, Dept Food Sci & Nutr, 13 Shungeng Rd, Jinan 250000, Peoples R China
1 shared publication Huiting Yv
Department of Neonatology, Children’s Hospital Affiliated to Shandong University
1 shared publicationJianguo Hu
Univ Jinan, Coll Culture & Tourism, Dept Food Sci & Nutr, 13 Shungeng Rd, Jinan 250000, Peoples R China
1 shared publicationJinlong Li
Nanjing Univ Chinese Med, Hosp Nanjing 2, Dept Lab Med, Nanjing 210003, Peoples R China
1 shared publication
Latest Publications
- Open Access
- 5 June 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14, 1708194
Clinical phenotypes and genetic mutation analysis of 45 neonatal-onset methylmalonic acidemia
Background: Methylmalonic acidemia (MMA), the most prevalent organic acidemia in China, is an autosomal recessive disorder. Neonatal-onset MMA often presents with non-specific manifestation, often causing diagnostic delays. Methods: A retrospective analysis was conducted on the clinical data, laboratory findings, and genetic information of 45 neonatal-onset MMA patients admitted to the Children's Hospital Affiliated to Shandong University from October 2016 to June 2024. Results: 1) Classification: 32 combined MMA, 13 isolated MMA. Median onset: 11 days. Common manifestations: feeding difficulties (60.0%), failure to thrive (57.8%), jaundice (46.7%), respiratory distress (40.0%), impaired consciousness (28.9%). Key labs: hyperammonemia (40.0%), macrocytic anemia (33.3%), granulocytopenia (31.1%). Hydrocephalus occurred in 3/31, abnormal EEGs in 15/19. Elevated C3, C3/C0, methylmalonic acid, and methylcitric acid were diagnostic. 2) Combined MMA had significantly lower methionine, blood ammonia, and C3/C0 vs. isolated MMA. Isolated MMA showed lower leukocyte counts ( p < 0.05). 3) Whole-exome sequencing: 31/32 (96.8%) had MMACHC mutations; c.609G>A recurrent (12/31). One had ABCD4 mutation. Isolated MMA: All 13 had MMUT mutations; c.729_730insTT common (46.2%). Missense mutations predominated. Conclusion: Neonatal-onset MMA presents with non-specific clinical phenotypes. Therefore, unexplained feeding difficulties, neutropenia, hyperammonemia, or seizures warrant prompt homocysteine, tandem MS, and urinary organic acid screening. Isolated MMA shows earlier free carnitine decline and higher ammonia. MMACHC c.609G>A and MMUT c.729_730insTT are recurrent in combined and isolated subtypes, respectively.
- 5 June 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14, 1708194
Open AccessClinical phenotypes and genetic mutation analysis of 45 neonatal-onset methylmalonic acidemia
Background: Methylmalonic acidemia (MMA), the most prevalent organic acidemia in China, is an autosomal recessive disorder. Neonatal-onset MMA often presents with non-specific manifestation, often causing diagnostic delays. Methods: A retrospective analysis was conducted on the clinical data, laboratory findings, and genetic information of 45 neonatal-onset MMA patients admitted to the Children's Hospital Affiliated to Shandong University from October 2016 to June 2024. Results: 1) Classification: 32 combined MMA, 13 isolated MMA. Median onset: 11 days. Common manifestations: feeding difficulties (60.0%), failure to thrive (57.8%), jaundice (46.7%), respiratory distress (40.0%), impaired consciousness (28.9%). Key labs: hyperammonemia (40.0%), macrocytic anemia (33.3%), granulocytopenia (31.1%). Hydrocephalus occurred in 3/31, abnormal EEGs in 15/19. Elevated C3, C3/C0, methylmalonic acid, and methylcitric acid were diagnostic. 2) Combined MMA had significantly lower methionine, blood ammonia, and C3/C0 vs. isolated MMA. Isolated MMA showed lower leukocyte counts ( p < 0.05). 3) Whole-exome sequencing: 31/32 (96.8%) had MMACHC mutations; c.609G>A recurrent (12/31). One had ABCD4 mutation. Isolated MMA: All 13 had MMUT mutations; c.729_730insTT common (46.2%). Missense mutations predominated. Conclusion: Neonatal-onset MMA presents with non-specific clinical phenotypes. Therefore, unexplained feeding difficulties, neutropenia, hyperammonemia, or seizures warrant prompt homocysteine, tandem MS, and urinary organic acid screening. Isolated MMA shows earlier free carnitine decline and higher ammonia. MMACHC c.609G>A and MMUT c.729_730insTT are recurrent in combined and isolated subtypes, respectively.
- 16 August 2022
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1225, 340267
An extracellular matrix biosensing mimetic for evaluating cathepsin as a host target for COVID-19
- 16 August 2022
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1225, 340267
An extracellular matrix biosensing mimetic for evaluating cathepsin as a host target for COVID-19
- 10 December 2021
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 6 (12) , 4499-4506
A Metal Ion-Controlled Molecular “Open Bridge” Detecting Oxidative Stress-Disrupted Apoptotic Signaling in Pediatric Neuroblastoma
Neuroblastoma is a metastatic tumor almost exclusively plaguing young children. To provide an early warning for timely medical interference that may prevent such tragedies from happening, we mimic the biomolecular pathology of this disease and have obtained an assay without using costly biomolecules such as antibodies and enzymes but can still sensitively detect trace level metal ions and metastatic marker proteins in the cerebrospinal fluid of neuroblastoma-bearing children in a one-step and reagentless fashion. Specifically, a surface-tethered “open bridge”-like molecular machine is designed. This probe, after interacting with cupric ions, can form an electrochemically active peroxidase-like artificial enzyme. Its activity first opens the probe, freeing the Bcl-2-targeting sequence of the probe to adopt the most favorable conformation, forming a noncovalent complex with Bcl-2. Then, the peroxidase-like activity of the probe induces the formation a robust fluorescence covalent linkage with the target protein. This fluorescence and electrochemical dual detection allows an analytical performance not inferior to the commercially available methods, pointing to possible clinical application in the early screening of pediatric metastatic conditions in the near future.
- 10 December 2021
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 6 (12) , 4499-4506
A Metal Ion-Controlled Molecular “Open Bridge” Detecting Oxidative Stress-Disrupted Apoptotic Signaling in Pediatric Neuroblastoma
Neuroblastoma is a metastatic tumor almost exclusively plaguing young children. To provide an early warning for timely medical interference that may prevent such tragedies from happening, we mimic the biomolecular pathology of this disease and have obtained an assay without using costly biomolecules such as antibodies and enzymes but can still sensitively detect trace level metal ions and metastatic marker proteins in the cerebrospinal fluid of neuroblastoma-bearing children in a one-step and reagentless fashion. Specifically, a surface-tethered “open bridge”-like molecular machine is designed. This probe, after interacting with cupric ions, can form an electrochemically active peroxidase-like artificial enzyme. Its activity first opens the probe, freeing the Bcl-2-targeting sequence of the probe to adopt the most favorable conformation, forming a noncovalent complex with Bcl-2. Then, the peroxidase-like activity of the probe induces the formation a robust fluorescence covalent linkage with the target protein. This fluorescence and electrochemical dual detection allows an analytical performance not inferior to the commercially available methods, pointing to possible clinical application in the early screening of pediatric metastatic conditions in the near future.